Correction: Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer

Oncotarget. 2019 Apr 2;10(26):2576. doi: 10.18632/oncotarget.26855.

¹ Medical Oncology Department, Catalan Institute of Oncology - Badalona, Hospital Universitari Germans Trias i Pujol, Badalona, Department of Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
² Medical Oncology Department, Catalan Institute of Oncology-Girona, Hospital Universitari Doctor Trueta Girona, Girona, Spain.
³ Molecular Biology Laboratory of Cancer Dr. Rosell, Can Ruti Campus: Institute Germans Trias i Pujol (IGTP), Catalan Institute of Oncology, Badalona, Spain.
⁴ Medical Oncology Department, Catalan Institute of Oncology - Hospital Duran i Reynalds, l'Hospitalet de Llobregat, Barcelona, Spain.
⁵ Medical Oncology Department, Hospital Parc Taulí, Sabadell, Barcelona, Spain.
⁶ Medical Oncology Department, Consorci Sanitari de Terrassa, Terrassa, Barcelona, Spain.
⁷ Research Nurse Team, Catalan Institute of Oncology - Badalona, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
⁸ Statistics Department, Fundació Germans Trias i Pujol, Badalona, Spain.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.25478.].